IP protection to support sustainable commercial development of microbiome-targeting applications. Discovering the influence of microorganisms on health, disease and wellbeing.
Microbiome targeting technology is a rapidly emerging, complex sector which improves human, animal, and crop health and well-being. Having actively advised on a full-range of IP matters involving manipulation and analysis of microbiomes for almost two decades, HGF has one of the most experienced teams in this area throughout Europe.
Specialising in therapeutic, diagnostic, nutraceutical, cosmetic and agricultural application, as well as related bioinformatics-powered innovations, the team is well versed in the challenges and opportunities for protecting and commercialising the whole spectrum of microbiome-related inventions, and assists the full range of microbiome-focused companies in developing robust IP strategies, including IP protection, freedom to operate, licensing, European patent opposition and litigation strategies.
HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …Event details
Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …Read article
HGF is a gold sponsor at the BioCap Conference 2022. The conference will be held on Thursday 22 September at the Alderley Park Conference Centre. It connects life sciences businesses, …Event details
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …Event details
HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …Read article
One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …Read article